The British-Swedish pharmaceutical major and the UK's medicines regulator said, "The vaccines produced by Oxford University in collaboration with AstraZeneca to protect against Covid-19 are safe and there is no evidence to suggest that the jabs are the cause behind blood clots as reported in some European countries."
The interventions come as the Netherlands became the latest country to suspend the use of the Oxford/AstraZeneca vaccine, followed by the Republic of Ireland, Bulgaria, Denmark, Norway and Iceland all pausing the administration of the vaccines as a precautionary measure after concerns raised around thrombotic events or clots.
The company said that safety is of “paramount importance” and the company is continually monitoring the safety of its vaccine.
“A careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and the UK with Covid-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” it said.